<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"	
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:media="http://search.yahoo.com/mrss/"
	>
<channel>
	<title>Women’s Health &#187; The Doctor&#039;s Channel</title>
	<atom:link href="http://www.thedoctorschannel.com/channels/womenshealth/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.thedoctorschannel.com</link>
	<description>Internet TV for Doctors</description>
	<lastBuildDate>Wed, 16 May 2012 23:34:19 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.2</generator>
			<item>
		<title>A second-look at node-negative or DCIS breast pathology worth it</title>
		<link>http://www.thedoctorschannel.com/view/a-second-look-at-node-negative-or-dcis-breast-pathology-worth-it/</link>
		<pubDate>Thu, 10 May 2012 21:09:22 +0000</pubDate> 
				<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Pathology & Lab Medicine]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[Surgery]]></category>
		<category><![CDATA[Women’s Health]]></category>
		<category><![CDATA[breast cancer]]></category>
		<category><![CDATA[dcis]]></category>
		<category><![CDATA[pathology]]></category>
		<category><![CDATA[second opinion]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=31610</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Getting a second opinion of surgical breast pathology often leads to changes that impact treatment in women with node-negative breast cancer or ductal carcinoma in situ (DCIS), clinicians with the British Columbia Cancer Agency (BCCA) in Vancouver have found. In an email to Reuters Health, first author Dr. Hagan F. -]]></description>
		
			<media:content duration="1:25" medium="video">
		<media:title><![CDATA[A second-look at node-negative or DCIS breast pathology worth it]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Getting a second opinion of surgical breast pathology often leads to changes that impact treatment in women with node-negative breast cancer or ductal carcinoma in situ (DCIS), clinicians with the British Columbia Cancer Agency (BCCA) in Vancouver have found. In an email to Reuters Health, first author Dr. Hagan F. -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/a-second-look-at-node-negative-or-dcis-breast-pathology-worth-it/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/05/Thumbnail_20120510epid003.jpg"/>
	<media:keywords><![CDATA[breast cancer,dcis,pathology,second opinion]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Targeted physical therapy effective for female bladder pain</title>
		<link>http://www.thedoctorschannel.com/view/targeted-physical-therapy-effective-for-female-bladder-pain-2/</link>
		<pubDate>Wed, 02 May 2012 18:47:15 +0000</pubDate> 
				<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[Urology]]></category>
		<category><![CDATA[Women’s Health]]></category>
		<category><![CDATA[bladder]]></category>
		<category><![CDATA[interstitial cystitis]]></category>
		<category><![CDATA[massage]]></category>
		<category><![CDATA[pain]]></category>
		<category><![CDATA[physical therapy]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=30795</guid>
		<description><![CDATA[NEW YORK (Reuters Health) &#8211; A randomized, multicenter trial has confirmed that myofascial physical therapy is an effective treatment for women with newly symptomatic interstitial cystitis/painful bladder syndrome (IC/PBS). IC/PBS affects between 2.7 and 6.5 percent of US women, which translates to about 3 to 8 million, according to the RAND IC Epidemiology Study, a -]]></description>
		
			<media:content duration="1:31" medium="video">
		<media:title><![CDATA[Targeted physical therapy effective for female bladder pain]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) &#8211; A randomized, multicenter trial has confirmed that myofascial physical therapy is an effective treatment for women with newly symptomatic interstitial cystitis/painful bladder syndrome (IC/PBS). IC/PBS affects between 2.7 and 6.5 percent of US women, which translates to about 3 to 8 million, according to the RAND IC Epidemiology Study, a -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/targeted-physical-therapy-effective-for-female-bladder-pain-2/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/05/Thumbnail_20120502drgd003.jpg"/>
	<media:keywords><![CDATA[bladder,interstitial cystitis,massage,pain,physical therapy]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Add-on bevacizumab slows progression of recurrent ovarian cancer</title>
		<link>http://www.thedoctorschannel.com/view/add-on-bevacizumab-slows-progression-of-recurrent-ovarian-cancer-2/</link>
		<pubDate>Wed, 25 Apr 2012 21:43:45 +0000</pubDate> 
				<category><![CDATA[Ob/Gyn]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Women’s Health]]></category>
		<category><![CDATA[Bevacizumab]]></category>
		<category><![CDATA[carboplatin ovarian cancer]]></category>
		<category><![CDATA[gemcitabine]]></category>
		<category><![CDATA[OCEANS trial]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=30200</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Progression-free survival (PFS) is significantly longer in women with recurrent ovarian cancer when bevacizumab is added to chemotherapy, a multicenter team reports in the Journal of Clinical Oncology online April 23. “As ovarian cancer becomes a chronic illness, treatments that prolong PFS, and therefore time without cytotoxic chemotherapy, become increasingly -]]></description>
		
			<media:content duration="1:18" medium="video">
		<media:title><![CDATA[Add-on bevacizumab slows progression of recurrent ovarian cancer]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Progression-free survival (PFS) is significantly longer in women with recurrent ovarian cancer when bevacizumab is added to chemotherapy, a multicenter team reports in the Journal of Clinical Oncology online April 23. “As ovarian cancer becomes a chronic illness, treatments that prolong PFS, and therefore time without cytotoxic chemotherapy, become increasingly -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/add-on-bevacizumab-slows-progression-of-recurrent-ovarian-cancer-2/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/04/Thumbnail_20120425drgd005.jpg"/>
	<media:keywords><![CDATA[Bevacizumab,carboplatin ovarian cancer,gemcitabine,OCEANS trial]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Age over 30 not a risk factor for hypothyroidism in pregnancy</title>
		<link>http://www.thedoctorschannel.com/view/age-over-30-not-a-risk-factor-for-hypothyroidism-in-pregnancy/</link>
		<pubDate>Wed, 18 Apr 2012 20:58:48 +0000</pubDate> 
				<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Ob/Gyn]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[Women’s Health]]></category>
		<category><![CDATA[hypothyroidism]]></category>
		<category><![CDATA[pregnancy]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=28338</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Women older than age 30 are no more likely than younger women to develop hypothyroidism in pregnancy, suggest results a study from the Czech Republic. Current (2011) guidelines from the American Thyroid Association include age over 30 as one of the risk factors for hypothyroidism in pregnancy. To verify whether -]]></description>
		
			<media:content duration="1:36" medium="video">
		<media:title><![CDATA[Age over 30 not a risk factor for hypothyroidism in pregnancy]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Women older than age 30 are no more likely than younger women to develop hypothyroidism in pregnancy, suggest results a study from the Czech Republic. Current (2011) guidelines from the American Thyroid Association include age over 30 as one of the risk factors for hypothyroidism in pregnancy. To verify whether -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/age-over-30-not-a-risk-factor-for-hypothyroidism-in-pregnancy/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/04/Thumbnail_20120418epid002.jpg"/>
	<media:keywords><![CDATA[hypothyroidism,pregnancy]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Consider adjuvant tamoxifen in ER-positive DCIS, experts advise</title>
		<link>http://www.thedoctorschannel.com/view/consider-adjuvant-tamoxifen-in-er-positive-dcis-experts-advise/</link>
		<pubDate>Fri, 13 Apr 2012 23:08:46 +0000</pubDate> 
				<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[Women’s Health]]></category>
		<category><![CDATA[dcis]]></category>
		<category><![CDATA[tamoxifen]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=28163</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Adjuvant tamoxifen after surgery and radiation reduces subsequent ipsilateral and contralateral breast cancers in women with estrogen-receptor (ER)-positive ductal carcinoma in situ (DCIS), according to the NSABP Protocol B-24 study. “The use of adjuvant tamoxifen should be considered for patients with DCIS,” Dr. D. Craig Allred from Washington University in -]]></description>
		
			<media:content duration="1:32" medium="video">
		<media:title><![CDATA[Consider adjuvant tamoxifen in ER-positive DCIS, experts advise]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Adjuvant tamoxifen after surgery and radiation reduces subsequent ipsilateral and contralateral breast cancers in women with estrogen-receptor (ER)-positive ductal carcinoma in situ (DCIS), according to the NSABP Protocol B-24 study. “The use of adjuvant tamoxifen should be considered for patients with DCIS,” Dr. D. Craig Allred from Washington University in -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/consider-adjuvant-tamoxifen-in-er-positive-dcis-experts-advise/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/04/Thumbnail_20120413clin011.jpg"/>
	<media:keywords><![CDATA[dcis,tamoxifen]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Low calcium intake ups absorption, increases stone risk</title>
		<link>http://www.thedoctorschannel.com/view/low-calcium-intake-ups-absorption-increases-stone-risk/</link>
		<pubDate>Wed, 28 Mar 2012 22:57:49 +0000</pubDate> 
				<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[Urology]]></category>
		<category><![CDATA[Women’s Health]]></category>
		<category><![CDATA[calcium]]></category>
		<category><![CDATA[kidney stones]]></category>
		<category><![CDATA[nephrolithiasis]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=27477</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Women with a history of nephrolithiasis have higher fractional calcium absorption, but consuming adequate calcium reduces fractional absorption and may help prevent kidney stones, new research shows. Based on these findings, doctors treating such patients should advise them not to reduce their calcium intake, Dr. Mathew D. Sorensen, an assistant -]]></description>
		
			<media:content duration="1:47" medium="video">
		<media:title><![CDATA[Low calcium intake ups absorption, increases stone risk]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Women with a history of nephrolithiasis have higher fractional calcium absorption, but consuming adequate calcium reduces fractional absorption and may help prevent kidney stones, new research shows. Based on these findings, doctors treating such patients should advise them not to reduce their calcium intake, Dr. Mathew D. Sorensen, an assistant -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/low-calcium-intake-ups-absorption-increases-stone-risk/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/03/Thumbnail_20120328epid004.jpg"/>
	<media:keywords><![CDATA[calcium,kidney stones,nephrolithiasis]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Bariatric surgery good for mom-to-be but not necessarily baby: study</title>
		<link>http://www.thedoctorschannel.com/view/bariatric-surgery-good-for-mom-to-be-but-not-necessarily-baby-study/</link>
		<pubDate>Fri, 09 Mar 2012 02:09:41 +0000</pubDate> 
				<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Ob/Gyn]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[Women’s Health]]></category>
		<category><![CDATA[Bariatric Surgery]]></category>
		<category><![CDATA[gestational diabetes]]></category>
		<category><![CDATA[pregnancy]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=26150</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Having weight loss surgery before having a child may be good for the mother but not necessarily the baby, hints research published this month in Obstetrics and Gynecology. “Our findings would suggest that bariatric surgery confers an improvement in maternal outcomes, but possibly at the expense of an increase in -]]></description>
		
			<media:content duration="1:48" medium="video">
		<media:title><![CDATA[Bariatric surgery good for mom-to-be but not necessarily baby: study]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Having weight loss surgery before having a child may be good for the mother but not necessarily the baby, hints research published this month in Obstetrics and Gynecology. “Our findings would suggest that bariatric surgery confers an improvement in maternal outcomes, but possibly at the expense of an increase in -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/bariatric-surgery-good-for-mom-to-be-but-not-necessarily-baby-study/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/03/Thumbnail_20120308clin008.jpg"/>
	<media:keywords><![CDATA[Bariatric Surgery,gestational diabetes,pregnancy]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Sunitinib plus docetaxel fails as first-line therapy for advanced breast cancer</title>
		<link>http://www.thedoctorschannel.com/view/sunitinib-plus-docetaxel-fails-as-first-line-therapy-for-advanced-breast-cancer/</link>
		<pubDate>Fri, 24 Feb 2012 20:21:30 +0000</pubDate> 
				<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[Women’s Health]]></category>
		<category><![CDATA[breast cancer]]></category>
		<category><![CDATA[docetaxel]]></category>
		<category><![CDATA[oncology]]></category>
		<category><![CDATA[Sunitinib]]></category>
		<category><![CDATA[Sutent]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=25558</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Adding the multitargeted tyrosine kinase inhibitor sunitinib (Sutent; Pfizer) to docetaxel did not improve clinical outcomes when used in the first-line setting in a phase III open-label study of women with HER2/neu-negative advanced breast cancer. The combination did improve the objective response rate but did not prolong survival time compared -]]></description>
		
			<media:content duration="01:30" medium="video">
		<media:title><![CDATA[Sunitinib plus docetaxel fails as first-line therapy for advanced breast cancer]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Adding the multitargeted tyrosine kinase inhibitor sunitinib (Sutent; Pfizer) to docetaxel did not improve clinical outcomes when used in the first-line setting in a phase III open-label study of women with HER2/neu-negative advanced breast cancer. The combination did improve the objective response rate but did not prolong survival time compared -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/sunitinib-plus-docetaxel-fails-as-first-line-therapy-for-advanced-breast-cancer/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/02/Thumbnail_20120224drgd013.jpg"/>
	<media:keywords><![CDATA[breast cancer,docetaxel,oncology,Sunitinib,Sutent]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Tension-free vaginal tape provides lasting relief of stress urinary incontinence</title>
		<link>http://www.thedoctorschannel.com/view/tension-free-vaginal-tape-provides-lasting-relief-of-stress-urinary-incontinence/</link>
		<pubDate>Mon, 13 Feb 2012 14:55:21 +0000</pubDate> 
				<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[Surgery]]></category>
		<category><![CDATA[Urology]]></category>
		<category><![CDATA[Women’s Health]]></category>
		<category><![CDATA[Tension free vaginal tape]]></category>
		<category><![CDATA[urinary incontinence]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=24789</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – For women with proven stress urinary incontinence, tension-free vaginal tape provides lasting relief, according to results of a 10-year follow-up study conducted in Italy. The 10-year results “seem to demonstrate that TVT is a highly effective option for the treatment of SUI, recording a very high cure rate with low -]]></description>
		
			<media:content duration="1:30" medium="video">
		<media:title><![CDATA[Tension-free vaginal tape provides lasting relief of stress urinary incontinence]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – For women with proven stress urinary incontinence, tension-free vaginal tape provides lasting relief, according to results of a 10-year follow-up study conducted in Italy. The 10-year results “seem to demonstrate that TVT is a highly effective option for the treatment of SUI, recording a very high cure rate with low -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/tension-free-vaginal-tape-provides-lasting-relief-of-stress-urinary-incontinence/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/02/Thumbnail_20120213clin002.jpg"/>
	<media:keywords><![CDATA[Tension free vaginal tape,urinary incontinence]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Some benefit seen with anastrozole after tamoxifen for early-stage breast cancer</title>
		<link>http://www.thedoctorschannel.com/view/some-benefit-seen-with-anastrozole-after-tamoxifen-for-early-stage-breast-cancer/</link>
		<pubDate>Fri, 27 Jan 2012 22:27:17 +0000</pubDate> 
				<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[Women’s Health]]></category>
		<category><![CDATA[anastrozole]]></category>
		<category><![CDATA[breast cancer]]></category>
		<category><![CDATA[estrogen receptor]]></category>
		<category><![CDATA[tamoxifen]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=24129</guid>
		<description><![CDATA[NEW YORK (Reuters Health) &#8211; Women with early-stage estrogen receptor-positive breast cancer fare somewhat better with 2 years of tamoxifen followed by 3 years of anastrozole than with 5 years of tamoxifen, an Austrian group reports in the Journal of Clinical Oncology online January 23. “The small efficacy benefits observed were driven by a lower -]]></description>
		
			<media:content duration="1:38" medium="video">
		<media:title><![CDATA[Some benefit seen with anastrozole after tamoxifen for early-stage breast cancer]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) &#8211; Women with early-stage estrogen receptor-positive breast cancer fare somewhat better with 2 years of tamoxifen followed by 3 years of anastrozole than with 5 years of tamoxifen, an Austrian group reports in the Journal of Clinical Oncology online January 23. “The small efficacy benefits observed were driven by a lower -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/some-benefit-seen-with-anastrozole-after-tamoxifen-for-early-stage-breast-cancer/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/01/Screen-shot-2012-01-27-at-5.25.44-PM.png"/>
	<media:keywords><![CDATA[anastrozole,breast cancer,estrogen receptor,tamoxifen]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
	</channel>
</rss>
